Evoke Pharma Inc. (EVOK)

[shalley]

Copy from Yahoo finance board:
The annual meeting of stockholders of Evoke Pharma, Inc. will be held by means of remote communication via a live webcast accessible at www.proxydocs.com/EVOK on May 5, 2021 at 8:30 a.m., Pacific Time. The annual meeting will be held exclusively online and you must register in advance as described below.

The annual meeting is being held for the following purposes:
1. To elect two directors for a three-year term to expire at the 2024 annual meeting of stockholders;

2.To consider and vote upon the ratification of the selection of BDO USA, LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2021;

3.To consider and vote upon, on an advisory basis, the compensation of our named executive officers as disclosed in this proxy statement pursuant to the compensation disclosure rules of the Securities and Exchange Commission;

4.To consider and vote upon the approval of an amendment to the Company’s Amended and Restated Certificate of Incorporation to increase the authorized number of shares of common stock from 50,000,000 to 100,000,000; and

5.To transact such other business as may be properly brought before the meeting or any adjournment or postponement thereof.

[shalley]

Are you still confident with EVOK?
Based on what was said about the sales in Q1, there should be a strong bounce back after so big drop. But so far the bounce is really weak. I am worried about this stock.

[Ruffieruff]

Lol. Someone covering some short positions today. This is going to be a slow ride north.

[shalley]

When can we get over 3?

[shalley]

Over 2.5 today and good volume !

[fishhunter]

It will be Tuesday, just not sure which week.

[Ruffieruff]

Gonna hold u too that. Lol

[shalley]

Hopefully. Wish sp can go up from this point.

[fishhunter]

Tuesday

[shalley]

When can this thing break 2.5?

[Ruffieruff]

Close to your guess. I doubled up this Am to drop my cost. Gl

[WolfofMia]

Yea way more at 5, but you know thieves will take the 2.50 also.

Hopefully not, but I shall wait.

Moved the funds to our baby AVXL.

[XenaLives]

Options - for the record:

[shalley]

Hopefully. I keep some cash.

[WolfofMia]

Waiting till next week to re-enter. maybe.

[WolfofMia]

Definitely short covering this morning.

I waiting till next week to buy they will try to make the 2.50 worthless.

To many contracts there to take down, once they are done covering.

IMO.

[shalley]

Yes. I was hoping to pick up big load at 1.5. Unfortunately it didn't drop so much. Only picked about 2k at about 2.25.

[WolfofMia]

Pretty good support at 2.20.

But I dont like they are trying to increase shelf from 50 to 100.

[XenaLives]

Historic short interest:

You can go to this link to check short interest in a stock:
http://nasdaqtrader.com/Trader.aspx?id=ShortInterest

Publication schedule is here:
http://nasdaqtrader.com/Trader.aspx?id=ShortIntPubSch

 
  
 Settlement Date Short Interest Percent Change Average Daily Share Volume Days to Cover 
  
 02/26/2021	731,718	   48.19	487,160 	1.50 
 02/12/2021	493,780    26.80      1,607,189 	1.00 
 01/29/2021	389,426	  (55.20)	392,221	        1.00 
 01/15/2021	869,306    56.41	594,270 	1.46 
 12/31/2020	555,785	   18.44	284,624	        1.95 
 12/15/2020	469,245	   37.48	221,047 	2.12 
 11/30/2020	341,315	   (4.35)	239,415 	1.43 
 11/13/2020	356,826	    0.21	245,884 	1.45 
 10/30/2020	356,079	   (38.63)	158,575 	2.25 
 10/15/2020	580,234	     8.49	214,582 	2.70 
 09/30/2020	534,830	   (11.35)	146,473 	3.65 
 09/15/2020	603,317	   (2.23)	357,353 	1.69 
 08/31/2020	617,095    (10.37)	350,440 	1.76 
 08/14/2020	688,489	    14.43	807,436 	1.00 
 07/31/2020	601,683	   (31.47)	283,036 	2.13 
 07/15/2020	877,985	   (27.82)	540,184 	1.63 
 06/30/2020    1,216,361    292.73     5,871,343 	1.00 
 06/15/2020	309,720	    13.81	760,429 	1.00 
 05/29/2020	272,149	   120.42     1,079,772 	1.00 
 05/15/2020	123,466	    25.79	234,941 	1.00 
 04/30/2020	98,150	   (2.72)	170,097 	1.00 
 04/15/2020	100,892	   (25.08)	86,918  	1.16 
 03/31/2020	134,670	   (42.92)	140,836 	1.00 
 03/13/2020	235,914    (7.86)	196,130 
  
 

[Ruffieruff]

Definitely an ugly beginning. Bought a day too early as usual. Lol

[shalley]

Will this drop to 1.5?

[WolfofMia]

Depends on Mr.Market tomorrow.

Either way I can wait to see what happens.

Facts are sales suck for reason xyz.

I didnt want this, but is reality for now.

[fishhunter]

....because it might not get to 1.50.
My guess is it closes tomorrow around 2.60

[WolfofMia]

My point exact, why not buy at 1-1.50 range?

I do realize it was a very short quarter.

But I also do realize is only $23K

Around how much of a loss I took lol (for now)

[fishhunter]

You do realize they didn’t really launch until the second week of January.
Today’s report was Q4, not Q1.
I bought lots more after hours.
It could go to 1.50....but I doubt it.
Listen to the cc replay.

[WolfofMia]

from $23K to a couple million? how?

[WolfofMia]

Took the hit and got out, only 1.5k shares left for the long run.

[Ruffieruff]

Ouch. I should have waited. Maybe I will have to double up tomorrow.

[fishhunter]

I suspect EVOK gets bought out late this year. Good time to buy after hours today. I didn’t expect any sales in Q4. Q1 will show a couple million and up and up.

[Ruffieruff]

What are you expecting here?

[Ruffieruff]

I just bought in today. Hopefully it turns out well. As far as Ferris and VTSI I unloaded a bunch of my shares from 4-550. I have a few left in case something crazy happens. Too many years and lost opportunities. I feel relieved. Gl here.

[fishhunter]

Forgot to mention, his recent CFO hire is an embarrassment. Obvious that it was a sloppy hire without any sort of in depth background check.

[Ruffieruff]

Hope I didn’t buy yours today. :)

[fishhunter]

Awesome time to be buying EVOK

[WolfofMia]

https://finance.yahoo.com/news/evoke-pharma-report-fourth-quarter-210500648.html

Game time March 11!

[WolfofMia]

Historically yes, but the company hasn`t made an announcement yet, which is odd in my opnion.

[XenaLives]

So it looks like earnings will be early next week...

[WolfofMia]

Yea, is a better mouse trap play here.

Sales and guidance this earnings are important for the bigger picture.

Which is BO.

[XenaLives]

Thanks for the response, I need to rebalance my portfolio today so took a taste.

[WolfofMia]

Word 16K shares deep :)

[stupified777]

Until they’re bought out, yes. I’ll be here.

[XenaLives]

Anyone still following this????

[jacksonpollack2015]

Dr.: So, in laymen speech, $EVOK is a long?

[DrGoodwrench]

The bigger market for this drug is for off label use as an anti-emetic for postoperative patients having nausea and/or vomiting. The 2021 Medicare PQRS measures will include reducing outpatient admits for nausea and vomiting and the only currently available non intravenous or oral medications to treat patients at home after surgery are Compazine suppositories ( serious side reactions and people hate suppositories), or very expensive Zofran ODT ( oral dissolving tablets) that when you are already nauseated are not a great solution. The Intranasal route of Metoclopramide will be the most readily tolerated and should also be the most effective as loss of GI motility from general Anesthesia and from Narcotic pain medications is the primary cause of nausea and vomiting in the first few days post-op. This HUGE market will be driven by physicians looking for a means to ensure they capture the 10% Medicare hold back of PQRS.

[stupified777]

Big investors are cashing out? 500k shares have exchanged hands today. Show the proof. I haven’t seen a Schedule 13D or 13G. Please post it if you have.

[stupified777]

Lol I like your logic. Yes, keep it up...all the way to $10.

[mikar]

The more you say this the higher it goes. So keep it up!! Thanks!!

[Babubd]

Guys, EVOK is an insiders P&D only. Big investors are cashing out. Save your hard earned money.

[stupified777]

Incremental moves to $10. Waiting patiently until fourth quarter sales come in! With the recent drastic move over $5 and touching $6 briefly over the last few days I feel something big is coming!

“The recent FDA approval of Gimoti, the first and only outpatient treatment option that bypasses the stomach to relieve symptoms in adults with acute and recurrent diabetic gastroparesis, marked the most significant milestone in our history,” said David A. Gonyer, R.Ph., President and CEO of Evoke Pharma. “We are currently focused on the commercial launch of Gimoti during the fourth quarter of 2020 with EVERSANA, our commercial partner. EVERSANA is working with us to fully implement our strategy, while leveraging their integrated suite of commercialization capabilities. Simultaneously, we have manufactured the first commercial batch of Gimoti with our contract manufacturing partner, Patheon. We believe that we will be well prepared to launch Gimoti and look forward to providing patients with diabetic gastroparesis the only outpatient non-oral treatment option to help improve gastroparesis patients’ quality of life.”

$EVOK

[Babubd]

Folks! Smart investors are cashing out as EVOK is an insiders P&D only. For the second quarter of 2020, net loss was approximately $7.0 million, or $0.28 per share, compared to a net loss of approximately $2.1 million, or $0.09 per share, for the same period of 2019....hahaha. Save your hard earned money.